TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ +0.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Minerva Neurosciences Inc (NERV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 95 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NERV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
63 56,900 51 46 43 37 33 30 28 98 94 95
48 42,002 36 31 28 22 18 16 13 83 79 80
47 40,913 35 31 27 21 17 15 12 82 33 25
47 40,913 35 31 27 21 17 15 12 82 78 75
15 14,869 15 15 15 15 15 15 15 15 15 15
0.0 0.0 0.0 0.0 – – – – – – – –
83 85,357 87 91 64 63 62 63 63 239 348 297
3.3 3,340 2.8 4.2 4.5 2.8 1.9 2.5 2.7 2.3 4.5 4.0
1.4 1,805 1.4 0.8 0.6 1.6 0.6 0.9 0.9 0.6 2.1 1.4
-20 -28,457 -37 -44 -22 -26 -29 -32 -35 -141 -254 -202
-388 -396,815 -405 -414 -391 -395 -399 -402 -405 -689 -814 -797
7.6 6.5 7.6 7.6 7.6 7.6 7.6 7.6 7.6 11 44 79

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?